Cargando…

Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures

Unresolved bone and soft tissue infections remain a great hindrance to fracture management worldwide, both economically and functionally for the patient. For this purpose, the benefits of local antibiotic administration besides systemic therapy have been elucidated. We present a retrospective descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Shunsuke, Maruo, Akihiro, Takayama, Hiroyuki, Harada, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789446/
https://www.ncbi.nlm.nih.gov/pubmed/35087693
http://dx.doi.org/10.1155/2022/2563939
_version_ 1784639765740519424
author Takahara, Shunsuke
Maruo, Akihiro
Takayama, Hiroyuki
Harada, Toshihiko
author_facet Takahara, Shunsuke
Maruo, Akihiro
Takayama, Hiroyuki
Harada, Toshihiko
author_sort Takahara, Shunsuke
collection PubMed
description Unresolved bone and soft tissue infections remain a great hindrance to fracture management worldwide, both economically and functionally for the patient. For this purpose, the benefits of local antibiotic administration besides systemic therapy have been elucidated. We present a retrospective descriptive analysis of six patients (4 males and 2 females) with acute deep infections after open fractures managed using the continuous local antibiotic perfusion (CLAP) therapy. After sufficient debridement, gentamicin solution concentrated at 1,200 μg/mL was continuously infused (2 mL/h) for 7–12 days by syringe pump through an inlet tube placed on the infected area. The antibiotics injected into the infected area were both collected and perfused by negative pressure using a negative-pressure wound therapy system. After an average of 9.5 days of CLAP therapy, symptoms of infection disappeared, and the bacterial culture was negative. There were no cases of recurrence during the follow-up period, and no complications, such as acute renal failure, ototoxicity, allergic or hypersensitivity reactions, and impaired fracture healing, were observed. All six cases were successfully managed with the CLAP therapy without any serious side effects. CLAP therapy may be a potential treatment option for acute deep infections after open fractures.
format Online
Article
Text
id pubmed-8789446
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87894462022-01-26 Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures Takahara, Shunsuke Maruo, Akihiro Takayama, Hiroyuki Harada, Toshihiko Case Rep Orthop Case Series Unresolved bone and soft tissue infections remain a great hindrance to fracture management worldwide, both economically and functionally for the patient. For this purpose, the benefits of local antibiotic administration besides systemic therapy have been elucidated. We present a retrospective descriptive analysis of six patients (4 males and 2 females) with acute deep infections after open fractures managed using the continuous local antibiotic perfusion (CLAP) therapy. After sufficient debridement, gentamicin solution concentrated at 1,200 μg/mL was continuously infused (2 mL/h) for 7–12 days by syringe pump through an inlet tube placed on the infected area. The antibiotics injected into the infected area were both collected and perfused by negative pressure using a negative-pressure wound therapy system. After an average of 9.5 days of CLAP therapy, symptoms of infection disappeared, and the bacterial culture was negative. There were no cases of recurrence during the follow-up period, and no complications, such as acute renal failure, ototoxicity, allergic or hypersensitivity reactions, and impaired fracture healing, were observed. All six cases were successfully managed with the CLAP therapy without any serious side effects. CLAP therapy may be a potential treatment option for acute deep infections after open fractures. Hindawi 2022-01-18 /pmc/articles/PMC8789446/ /pubmed/35087693 http://dx.doi.org/10.1155/2022/2563939 Text en Copyright © 2022 Shunsuke Takahara et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Series
Takahara, Shunsuke
Maruo, Akihiro
Takayama, Hiroyuki
Harada, Toshihiko
Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title_full Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title_fullStr Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title_full_unstemmed Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title_short Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures
title_sort continuous local antibiotics perfusion therapy for acute deep infections after open fractures
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789446/
https://www.ncbi.nlm.nih.gov/pubmed/35087693
http://dx.doi.org/10.1155/2022/2563939
work_keys_str_mv AT takaharashunsuke continuouslocalantibioticsperfusiontherapyforacutedeepinfectionsafteropenfractures
AT maruoakihiro continuouslocalantibioticsperfusiontherapyforacutedeepinfectionsafteropenfractures
AT takayamahiroyuki continuouslocalantibioticsperfusiontherapyforacutedeepinfectionsafteropenfractures
AT haradatoshihiko continuouslocalantibioticsperfusiontherapyforacutedeepinfectionsafteropenfractures